CD200 has been associated with tumour progression and poor prognosis in several cancers [245,246] and is over-expressed in CRC with markers for CSC [247], suggesting that tumour-initiating CSC may evade immune system detection through CD200-induced suppression of T-cell-mediated immune responses. This evidence concerns the gene CD200 and cancer.